Agreement supports improved clinical outcomes through survivorship care plans that enable earlier detection and intervention for treatment-related side effects and disease recurrence
ATLANTA US — Thursday, February 1, 2018
Elekta (EKTA-B.ST) today announced that it is has entered into a reseller agreement with Equicare Health
, a leader in developing chronic care models for cancer survivorship that improve patient outcomes and maximize cancer centers’ operational efficiencies. Under the terms of the agreement, Elekta will now offer EQUICARE CS™ and Equicare’s Active Patient Portal to current and future users of Elekta’s MOSAIQ® Oncology Electronic Health Record (EHR). EQUICARE CS and the Active Patient Portal complement MOSAIQ, facilitating communication between patients and clinicians with no geographic restrictions. Patients can receive updates on their care plans, provide feedback and patient reported outcomes through the platform. Clinical information is integrated into MOSAIQ directly from EQUICARE CS.
MOSAIQ is a leading open system that also provides actionable analytics to support improvements in the quality and cost of care. MOSAIQ is designed for interoperability with a broad array of digital health solutions to drive the open exchange of information and promote an all-inclusive workflow empowering patient care providers.
“The evolving needs of our customer base require us to think beyond what individual software solutions can offer,” said Margaret Nash, Global VP of Sales for Equicare. “Equicare’s products provide a unique and much-needed solution for efficiently managing and communicating with cancer patients. Cancer centers using our digital solutions in the context of MOSAIQ’s comprehensive EHR will now have a powerful system for connecting these patient interactions to the treatment management process. This allows an entire care team to document and review a patient’s complete history, starting as early as the patient’s first screening visit and extending well beyond the last day of treatment, improving patient outcomes while optimizing the use of oncology resources.”
EQUICARE CS is used to coordinate cancer care, manage patient navigation and facilitate the creation of survivorship plans based on recommendations from the Institute of Medicine and the American Society of Clinical Oncology. Patient navigation and survivorship plans are both required for cancer care centers to receive accreditation from the Commission on Cancer. The Active Patient Portal allows patients undergoing cancer treatment to access the latest medical information, stay on top of scheduled appointments, lab results and medical notes, as well as send/receive secure messages with care team members. It also provides insight into patient populations by aggregating valuable data collected in questionnaires that can help measure long-term clinical outcomes for entire patient populations.
“Elekta is committed to ensuring that our digital solutions interface seamlessly with systems and applications across the evolving healthcare ecosystem that share our goal of advancing patient care,” said Andrew Wilson, Vice President of Global Marketing for Software Solutions at Elekta. “We believe that the combination of MOSAIQ and Equicare’s offerings gives users unparalleled resources for effectively managing the entire oncology care continuum and improving survival and quality of life for cancer survivors.”
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com